Showing results 1 to 20 of 46
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| openAccess |  | 6-Sep-2011 | 1,2,4-tiadiazoles-5-imino sustituidos útiles en el tratamiento de enfermedades neurodegenerativas | Loza García, María Isabel; Martínez, Ana  ; Pérez Fernández, Daniel Ignacio ; Brea Floriani, José; Cadavid Torres, María Isabel; Palomo, Valle ; Gil, Carmen ; Pérez Castillo, Ana ; Pérez Martín, María Concepción | solicitud de patente |
| closedAccess |  | 28-Jun-2016 | 3,4-dihydroxyphenylalanine peptides as non-perturbative quantum dot sensors of aminopeptidase | Palomo, Valle ; Díaz, Sebastián A.; Stewart, Michael H.; Susumu, Kimihiro; Medintz, Igor L.; Dawson, Philip E. | artículo |
| closedAccess |  | 2012 | 5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3 | Palomo, Valle ; Pérez, Daniel I.; Pérez, Concepción; Morales-García, José A. ; Soteras, Ignacio ; Alonso-Gil, Sandra ; Encinas, Arantxa; Castro, Ana ; Campillo, Nuria E. ; Pérez Castillo, Ana ; Gil, Carmen ; Martínez, Ana | artículo |
| openAccess |  | 12-Sep-2020 | CdSe quantum dots evaluation in primary cellular models or tissues derived from patients | Tosat-Bitrian, Carlota ; Palomo, Valle | artículo |
| closedAccess |  | 2014 | Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: Two relevant therapeutic targets for neurological disorders | Morales-García, José A. ; Palomo, Valle ; Redondo, Miriam ; Alonso-Gil, Sandra ; Gil, Carmen ; Martínez, Ana ; Pérez Castillo, Ana | artículo |
| openAccess |  | Apr-2017 | Drugs on clinical development for the treatment of amyotrophic lateral sclerosis | Martínez, Ana ; Palomo, Valle ; Pérez, Daniel I.; Gil, Carmen | artículo |
| closedAccess |  | 2013 | Dual inhibitor of PDE7 and GSK-3 - VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice | Lipina, Tatiana V.; Palomo, Valle ; Gil, Carmen ; Martínez, Ana ; Roder, John C. | artículo |
| closedAccess |  | 31-Jul-2018 | Efficient assembly of quantum dots with homogenous glycans derived from natural N-linked glycoproteins | Palomo, Valle ; Cistrone, Philip A; Zhan, Naiqian; Palui, Goutam; Mattoussi, Hedi; Philip E. Dawson | artículo |
| closedAccess |  | 2011 | Exploring the binding sites of glycogen synthase kinase 3. identification and characterization of allosteric modulation cavities | Palomo, Valle ; Soteras, Ignacio ; Perez, Daniel I.; Pérez, Concepción; Gil, Carmen ; Campillo, Nuria E. ; Martínez, Ana | artículo |
| openAccess |  | 21-Nov-2016 | Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2014-2015) | Palomo, Valle ; Martínez, Ana | artículo |
| closedAccess |  | 2012 | Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo | Morales-García, José A. ; Luna Medina, Rosario de ; Alonso-Gil, Sandra ; Sanz-SanCristóbal, Marina ; Palomo, Valle ; Gil, Carmen ; Santos, Ángel; Martínez, Ana ; Pérez Castillo, Ana | artículo |
| closedAccess |  | 2011 | Glycogen synthase kinase 3 inhibitors promote adult hippocampal neurogenesis | Morales-García, José A. ; Palomo, Valle ; Gil, Carmen ; Martínez, Ana ; Santos, Ángel; Pérez Castillo, Ana | póster de congreso |
| closedAccess |  | 2013 | Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease | Morales-García, José A. ; Susín, Cristina ; Alonso-Gil, Sandra ; Pérez, Daniel I.; Palomo, Valle ; Pérez, Concepción; Conde, Santiago ; Santos, Ángel; Gil, Carmen ; Martínez, Ana ; Pérez Castillo, Ana | artículo |
| closedAccess |  | 2014 | Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice | Franklin, Aimee V.; King, Margaret K.; Palomo, Valle ; Martínez, Ana ; McMahon Lori L.; Jope, Richard S. | artículo |
| openAccess |  | 30-Aug-2012 | GSK-3 Inhibitors that can be used in neurodegenerative and inflammatory mseases, cancer, diabetes and in regenerative processes | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Perez, D.I.; Luque Garriga, Francisco Javier | patente |
| openAccess |  | 4-Apr-2013 | Heterocyclic GSK-3 allosteric modulators | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Pérez Fernández, Daniel Ignacio ; Reyes Rodríguez, Julio Alberto | patente |
| openAccess |  | 26-Feb-2015 | Heterocyclic GSK-3 allosteric modulators | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Pérez Fernández, Daniel Ignacio ; Reyes Rodríguez, Julio Alberto | solicitud de patente |
| openAccess |  | 12-Sep-2017 | Heterocyclic GSK-3 allosteric modulators | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Pérez Fernández, Daniel Ignacio ; Reyes Rodríguez, Julio Alberto | patente |
| openAccess |  | 7-Mar-2017 | Heterocyclic GSK-3 allosteric modulators | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Pérez Fernández, Daniel Ignacio ; Reyes Rodríguez, Julio Alberto | patente |
| openAccess |  | 27-Sep-2014 | Heterocyclic GSK-3 allosteric modulators | Martínez, Ana ; Gil, Carmen ; Palomo, Valle ; Pérez Martín, María Concepción; Pérez Fernández, Daniel Ignacio ; Reyes Rodríguez, Julio Alberto | solicitud de patente |
